Investigation of the Factors Responsible for the Poor Oral Bioavailability of Acacetin in Rats: Physicochemical and Biopharmaceutical Aspects
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Han, Dong-Gyun | - |
dc.contributor.author | Cha, Eunju | - |
dc.contributor.author | Joo, Jeongmin | - |
dc.contributor.author | Hwang, Ji Sun | - |
dc.contributor.author | Kim, Sanghyun | - |
dc.contributor.author | Park, Taeuk | - |
dc.contributor.author | Jeong, Yoo-Seong | - |
dc.contributor.author | Maeng, Han-Joo | - |
dc.contributor.author | Kim, Sang-Bum | - |
dc.contributor.author | Yoon, In-Soo | - |
dc.date.available | 2021-03-22T01:41:00Z | - |
dc.date.created | 2021-02-09 | - |
dc.date.issued | 2021-02 | - |
dc.identifier.issn | 1999-4923 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/80511 | - |
dc.description.abstract | Acacetin, an important ingredient of acacia honey and a component of several medicinal plants, exhibits therapeutic effects such as antioxidative, anticancer, anti-inflammatory, and anti-plasmodial activities. However, to date, studies reporting a systematic investigation of the in vivo fate of orally administered acacetin are limited. Moreover, the in vitro physicochemical and biopharmaceutical properties of acacetin in the gastrointestinal (GI) tract and their pharmacokinetic impacts remain unclear. Therefore, in this study, we aimed to systematically investigate the oral absorption and disposition of acacetin using relevant rat models. Acacetin exhibited poor solubility (≤119 ng/mL) and relatively low stability (27.5–62.0% remaining after 24 h) in pH 7 phosphate buffer and simulated GI fluids. A major portion (97.1%) of the initially injected acacetin dose re-mained unabsorbed in the jejunal segments, and the oral bioavailability of acacetin was very low at 2.34%. The systemic metabolism of acacetin occurred ubiquitously in various tissues (particularly in the liver, where it occurred most extensively), resulting in very high total plasma clearance of 199 ± 36 mL/min/kg. Collectively, the poor oral bioavailability of acacetin could be attributed mainly to its poor solubility and low GI luminal stability. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.relation.isPartOf | Pharmaceutics | - |
dc.title | Investigation of the Factors Responsible for the Poor Oral Bioavailability of Acacetin in Rats: Physicochemical and Biopharmaceutical Aspects | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000623019500001 | - |
dc.identifier.doi | 10.3390/pharmaceutics13020175 | - |
dc.identifier.bibliographicCitation | Pharmaceutics, v.13, no.2 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85100155749 | - |
dc.citation.title | Pharmaceutics | - |
dc.citation.volume | 13 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | Maeng, Han-Joo | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Acacetin | - |
dc.subject.keywordAuthor | Bioavailabil-ity | - |
dc.subject.keywordAuthor | Gastrointestinal absorption | - |
dc.subject.keywordAuthor | Solubility | - |
dc.subject.keywordAuthor | Stability | - |
dc.subject.keywordAuthor | Tissue metabolism | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.